Conference Coverage: COA 2024
Coverage from the Community Oncology Alliance 2024 Community Oncology Conference, held April 3-5, 2024, in Orlando, Florida.
Natalie Dickson, MD, MMHC, FASCO, FACP, of Tennessee Oncology Discusses Cutting-Edge Cancer Care Initiatives
AHN Cancer Institute Raises the Quality and Value Bar by Listening to Patients
Kathy Oubre, MS, on Mitigating Challenges When Adopting New Payment Models
At Hearing on Recurring Cancer Drug Shortages, Rural Areas Come Into Focus
“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
Raymond Thertulien, MD, PhD, on How Abnormalities Drive Treatment Choices in Multiple Myeloma
May 2024 Health Equity News
May 2024 News From Strategic Alliance Partners
Florida Cancer Specialists & Research Institute launches a new precision medicine venture; Tennessee Oncology announces promotions.
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges.
Follow-Up Needs for Blood Cancer Survivors May Determine Best Type of Provider
Differing characteristics of the patient and their disease may mean certain providers—academic oncologists, community oncologists, and primary care physicians—may be best suited for follow-up care.
